7 unchanged sentences
3.1 August 8, 2024
+Added: First Supplemental Indenture, dated as of March 17, 2025, by and between the Company and U.S.
+Added: Bank Trust Company, National Association, as Trustee.
+Added: 4.1 March 17, 2025
Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
10 unchanged sentences
Filed herewith.
−Removed: This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
+Added: This certification is deemed furnished, not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
IMMUNOCORE HOLDINGS PLC
−Removed: November 6, 2024
+Added: May 7, 2025 By:
/s/ Bahija Jallal
2 unchanged sentences
(On Behalf of the Registrant and as Principal Executive Officer)
−Removed: November 6, 2024
−Removed: /s/ Brian Di Donato
−Removed: Brian Di Donato
+Added: May 7, 2025 By:
+Added: /s/ Travis Coy
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.